| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0004867413488220 |
| P953 | full work available at URL | https://journals.sagepub.com/doi/full-xml/10.1177/0004867413488220 |
| https://journals.sagepub.com/doi/pdf/10.1177/0004867413488220 | ||
| P698 | PubMed publication ID | 23636913 |
| P2093 | author name string | Karan Makhija | |
| Satish Karunakaran | |||
| P2860 | cites work | Neuropsychiatric Disease and Treatment | Q15716332 |
| Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 | ||
| The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation | Q24289552 | ||
| The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus | Q24615884 | ||
| Cytokines sing the blues: inflammation and the pathogenesis of depression | Q24633065 | ||
| Neuro endocrinology letters | Q26839541 | ||
| Japanese journal of psychopharmacology | Q26842315 | ||
| Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene | Q27860482 | ||
| Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha | Q28241574 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action | Q29615696 | ||
| A meta-analysis of cytokines in major depression | Q29617325 | ||
| Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression | Q29617326 | ||
| Serotonin transporter gene, depressive symptoms, and interleukin-6. | Q33573734 | ||
| Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions. | Q33679060 | ||
| Contextual fear, gestalt memories, and the hippocampus | Q33913259 | ||
| Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. | Q33939777 | ||
| Stress and depression: possible links to neuron death in the hippocampus | Q34134017 | ||
| Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants | Q34211475 | ||
| Inflammatory mechanisms in major depressive disorder | Q34214042 | ||
| Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression | Q34242827 | ||
| Depression: an inflammatory illness? | Q34261855 | ||
| The role of immune genes in the association between depression and inflammation: a review of recent clinical studies | Q34266887 | ||
| Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels | Q34315488 | ||
| Course of illness, hippocampal function, and hippocampal volume in major depression | Q34331120 | ||
| Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade | Q43771417 | ||
| Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies | Q44066592 | ||
| Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases | Q44595357 | ||
| Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression | Q44638979 | ||
| Antioxidant enzyme activities and oxidative stress in affective disorders | Q44838705 | ||
| Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients | Q46075640 | ||
| An open label trial of C-1073 (mifepristone) for psychotic major depression | Q46152690 | ||
| Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. | Q46705565 | ||
| Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression | Q46921439 | ||
| Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist | Q47421203 | ||
| Fish consumption and major depression | Q47757469 | ||
| Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis | Q48402159 | ||
| Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis | Q48462840 | ||
| The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. | Q48545109 | ||
| Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses | Q48562222 | ||
| Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study | Q48715974 | ||
| Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. | Q51059710 | ||
| Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study | Q51776486 | ||
| Interleukin-1 beta -511C/T genetic polymorphism is associated with age of onset of geriatric depression | Q51865626 | ||
| Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory | Q51970444 | ||
| Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression | Q51996803 | ||
| Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders | Q52957904 | ||
| Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression | Q56767079 | ||
| Lower serum vitamin E concentrations in major depression | Q56767310 | ||
| Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion | Q56767354 | ||
| Indicators of immune activation in major depression | Q56767446 | ||
| Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression | Q56767554 | ||
| A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids | Q59664128 | ||
| Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls | Q60727680 | ||
| Cytokine production and serum proteins in depression | Q71695760 | ||
| Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells | Q71703865 | ||
| Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression | Q72674139 | ||
| Cytokine effects on glutamate uptake by human astrocytes | Q73644761 | ||
| Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress | Q80199153 | ||
| Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression | Q84840663 | ||
| The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine | Q34496400 | ||
| Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis | Q34511667 | ||
| The macrophage theory of depression | Q34607619 | ||
| A mechanism converting psychosocial stress into mononuclear cell activation | Q34762549 | ||
| Immune system to brain signaling: neuropsychopharmacological implications. | Q34769827 | ||
| The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression | Q34904703 | ||
| Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis | Q34978595 | ||
| Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment | Q35017009 | ||
| Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology | Q35356872 | ||
| Is Depression an Inflammatory Disorder? | Q35774501 | ||
| Cytokines and glucocorticoid receptor signaling. Relevance to major depression | Q36101717 | ||
| Glucocorticoids, cytokines and brain abnormalities in depression | Q36442019 | ||
| Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment | Q36442043 | ||
| The fibroblast growth factor system and mood disorders. | Q36456340 | ||
| Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression | Q36637116 | ||
| What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? | Q36777518 | ||
| The neurogenesis hypothesis of affective and anxiety disorders: Are we mistaking the scaffolding for the building? | Q36972430 | ||
| Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression | Q37126943 | ||
| Depression and Hippocampal Neurogenesis: A Road to Remission? | Q37131367 | ||
| Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study | Q37208545 | ||
| Neuropsychiatric disorders related to interferon and interleukins treatment | Q37344751 | ||
| Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface | Q37351319 | ||
| Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management | Q37374868 | ||
| Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study | Q37408142 | ||
| A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness | Q37752880 | ||
| In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression | Q37786688 | ||
| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors | Q37799094 | ||
| Inflammation and depression: why poststroke depression may be the norm and not the exception. | Q37849347 | ||
| The neurobiology of depression | Q37984000 | ||
| Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. | Q38410039 | ||
| Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor | Q39560411 | ||
| The dexamethasone suppression test for melancholia | Q40342019 | ||
| A review on the acute phase response in major depression | Q40385174 | ||
| Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans | Q40428160 | ||
| Evidence for an immune response in major depression: a review and hypothesis | Q40501767 | ||
| Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 828-839 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Australian and New Zealand Journal of Psychiatry | Q4824838 |
| P1476 | title | The role of inflammatory cytokines on the aetiopathogenesis of depression | |
| P478 | volume | 47 |
| Q50531503 | Anti-Yo Antibodies in Children With ADHD: First Results About Serum Cytokines |
| Q33844389 | Antidepressant-Like Effect of the Endogenous Neuroprotective Amine, 1MeTIQ in Clonidine-Induced Depression: Behavioral and Neurochemical Studies in Rats |
| Q34277385 | Common mental disorder symptoms among patients with malaria attending primary care in Ethiopia: a cross-sectional survey |
| Q40809115 | Habitual physical activity levels predict treatment outcomes in depressed adults: A prospective cohort study. |
| Q37357893 | Impact of antidepressants on cytokine production of depressed patients in vitro |
| Q91856535 | Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors |
| Q36846411 | Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Alleviates Doxorubicin-Induced Depressive-Like Behaviors and Neurotoxicity in Rats: Involvement of Oxidative Stress and Neuroinflammation |
| Q47622291 | Neurobiological mechanisms of exercise and psychotherapy in depression: The SPeED study-Rationale, design, and methodological issues |
| Q37260128 | Neurobiology of major depressive disorder |
| Q46146286 | Opinions, data and policy |
| Q33680142 | Raised serum proinflammatory cytokines in Alzheimer's disease with depression |
| Q34053640 | Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions. |
| Q58106998 | Resveratrol exerts a protective effect in chronic unpredictable mild stress-induced depressive-like behavior: involvement of the AKT/GSK3β signaling pathway in hippocampus |
| Q28595805 | Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: involvement of the neuroinflammatory pathway |
Search more.